Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Milestone Scientific (MLSS) Equity Average (2016 - 2025)

Historic Equity Average for Milestone Scientific (MLSS) over the last 15 years, with Q3 2025 value amounting to $2.9 million.

  • Milestone Scientific's Equity Average fell 6118.93% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year decrease of 6118.93%. This contributed to the annual value of $6.9 million for FY2024, which is 2408.68% down from last year.
  • Per Milestone Scientific's latest filing, its Equity Average stood at $2.9 million for Q3 2025, which was down 6118.93% from $3.9 million recorded in Q2 2025.
  • In the past 5 years, Milestone Scientific's Equity Average ranged from a high of $18.4 million in Q2 2021 and a low of $2.9 million during Q3 2025
  • In the last 5 years, Milestone Scientific's Equity Average had a median value of $8.6 million in 2023 and averaged $10.3 million.
  • As far as peak fluctuations go, Milestone Scientific's Equity Average surged by 146137.87% in 2021, and later tumbled by 6118.93% in 2025.
  • Over the past 5 years, Milestone Scientific's Equity Average (Quarter) stood at $16.3 million in 2021, then tumbled by 33.56% to $10.8 million in 2022, then tumbled by 30.57% to $7.5 million in 2023, then decreased by 13.0% to $6.5 million in 2024, then plummeted by 54.88% to $2.9 million in 2025.
  • Its last three reported values are $2.9 million in Q3 2025, $3.9 million for Q2 2025, and $5.1 million during Q1 2025.